Hiroaki Kusaka

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

Bo-Wen Lin, Nobutaka Koibuchi, Yu Hasegawa et al. · Cardiovascular Diabetology · 2014 · 422 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen–specific IgE production by stimulation of IL-12 production in mice

Shinji Murosaki, Yoshihiro Yamamoto, Kazue Ito et al. · Journal of Allergy and Clinical Immunology · 1998 · 270 citations · Full text

Life Sciences, Immunology, Microbiology +16

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome

Hiroaki Kusaka, Nobutaka Koibuchi, Yu Hasegawa et al. · Cardiovascular Diabetology · 2016 · 152 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Immunopotentiating Activity of Nigerooligosaccharides for the T Helper 1-Like Immune Response in Mice

Shinji Murosaki, Koutarou Muroyama, Yoshihiro Yamamoto et al. · Bioscience Biotechnology and Biochemistry · 1999 · 79 citations · Full text

Life Sciences, Immunology, Microbiology +12

Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction

Yasuhiro Izumiya, Shinsuke Hanatani, Yuichi Kimura et al. · Canadian Journal of Cardiology · 2013 · 77 citations

Medicine, Cardiology, Internal Medicine +11